Sculptor Capital LP Evolus, Inc. Transaction History

Sculptor Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $4,964 - $8,228	-1,700 Reduced 1.82%	91,600 $307,000
Q3 2020 Nov 12, 2020	BUY	$3.03 - $5.48 $176,043 - $318,388	58,100 Added 165.06%	93,300 $364,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $42,713 - $74,657	12,100 Added 52.38%	35,200 $186,000
Q3 2019 Nov 14, 2019	SELL	$13.91 - $19.87 $464,594 - $663,658	-33,400 Reduced 59.12%	23,100 $360,000
Q2 2019 Aug 14, 2019	SELL	$13.19 - $28.36 $290,180 - $623,920	-22,000 Reduced 28.03%	56,500 $826,000
Q1 2019 May 13, 2019	BUY	$12.43 - $28.91 $975,755 - $2.27 Million	78,500 New	78,500 $0

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.